By recruiting DCs and macrophages to phagocytize dying and/or dead cancer cells and enhancing the processing/presentation of tumour-associated antigens to T cells, OxPt/DHA may have increased the density of CD8+ T cells in tumours to potentiate checkpoint blockade immunotherapy. This evidence concerns the gene CD8A and neoplasm.